cd38 inhibitor and 5-amino-1mq synergy nad+ Inhibition of by 78c Enhanced NAD+, Alleviated Inflammation, Decreased Oxidative Stress in Old Murine Macrophages Induced by Oral Pathogens CD38 as theranostic target in
CD38 as theranostic target in oncology Journal of Translational Medicine Springer Nature Link Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control ScienceDirect Heavy chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs Scientific Reports Frontiers Nicotinamide N methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers
Pay in 4 interest-free payments of $5.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15




